SciELO - Scientific Electronic Library Online

 
vol.45 suppl.3Vaccines against human papillomavirus and perspectives for the prevention and control of cervical cancerRecommendations for cervical cancer screening programs in developing countries: the need for equity and technological development author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Salud Pública de México

Print version ISSN 0036-3634

Abstract

VILLA, Luisa Lina. Vaccines against papillomavirus infections and disease. Salud pública Méx [online]. 2003, vol.45, suppl.3, pp.443-448. ISSN 0036-3634.

Squamous cell carcinoma of the uterine cervix is the second cause of cancer-related deaths in women, the higher incidence being observed in developing countries. Infection with oncogenic types of human papillomavirus (HPV) is considered the major risk factor for the development of malignancies in the uterine cervix. However, HPV is considered to be a necessary but not sufficient cause for cervical cancer and, therefore, other factors contribute to the carcinogenic process, both present in the environment and from the host. Studies performed in animals, and more recently in humans, indicate that vaccination against the capsid proteins of the virus can prevent efficiently from infection. Furthermore, therapeutic vaccines are under investigation aiming the regression of papillomavirus induced tumors. The scientific basis for the development of papillomavirus vaccines and present status of clinical trials will be addressed in this chapter.

Keywords : papillomavirus; vaccine; cancer of the uterine cervix; prophylaxis.

        · abstract in Spanish     · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License